There are 2867 resources available
1131P - Overall survival after treatment with first-line crizotinib or alectinib in patients with stage IV NSCLC and ALK rearrangement: A real-world nationwide cohort study from the Netherlands
Presenter: Marjolein Tilkema-Tiebosch
Session: Poster session 15
859P - The influence of hematologic malignancies on response to immune checkpoint inhibition in patients with advanced melanoma
Presenter: Olivier van Not
Session: Poster session 03
1701P - Consensus molecular subtypes in late-stage colorectal cancer
Presenter: Andreas Bjerrum
Session: Poster session 11
1132P - Prevalence of the synonymous EGFR Q787Q variant in Mexican patients with non-small cell lung cancer
Presenter: Maritza Ramos-Ramirez
Session: Poster session 15
860P - The IOpener study: Tyrosine kinase activity in peripheral lymphocytes to predict durable response to immune checkpoint inhibition in patients with advanced melanoma
Presenter: Karlijn de Joode
Session: Poster session 03
1702P - Comutations in DNA damage repair pathway and its correlations with potential biomarkers for colorectal cancer immunotherapy in a Chinese cohort
Presenter: Ganggang Shi
Session: Poster session 11
1133P - Additional practice-informing adverse event patterns and management in the KRYSTAL-1 phase II study of adagrasib (MRTX849) in patients with KRASG12C-mutated NSCLC
Presenter: Jun Zhang
Session: Poster session 15
861P - Association of genetic variants in JAK/STAT signaling pathway with cutaneous melanoma susceptibility
Presenter: Carmen Passos Lima
Session: Poster session 03
1703P - The effect of CA4 on lung adenocarcinoma immune microenvironment
Presenter: Leen Al-Kraimeen
Session: Poster session 11